A team at DukeUniversityMedicalCenter was able to tone down appetite and promote weight loss, while improving the body’s ability to handle blood sugar levels by blocking a brain enzyme, CaMKK2.

The pharmaceutical industry is pressing the Food and Drug Administration for greater freedom to give doctors copies of scientific studies about experimental uses of their drugs. And the FDA is considering lighter restrictions. Does this mean we will get label disclaimers like nutritional products? Will manufacturers have put on the …

Canadian, French and British researchers have identified a DNA sequence that controls the variability of blood glucose levels in people. This is a potentially significant discovery because, 80 per cent of the risk of cardiovascular disease is related to a blood glucose level just above the average and high blood glucose …

Yes, you can stop diabetes before it begins, but you won’t receive the care you need if you don’t even know you have the problem. Screening is now recommended for everyone beginning at 45 years of age.

New analysis of a landmark study data Identifies major predictors of new-onset diabetes (NOD) among hypertensives. Of 19,257 randomized patients in the study, 14,120 were considered “at risk” of developing diabetes at baseline, and 1,366 (9.7%) subsequently developed NOD during follow-up (median duration, 5.5 years).

Aspirin-like compounds (salicylates) can claim another health benefit: increasing the amount of insulin produced by otherwise healthy obese people. Obesity is associated with insulin resistance, the first step toward type 2 diabetes.

A widely used class of diabetes medications appears to be associated with an increased risk for fractures, according to a new report in the Archives of Internal Medicine

Following a regular exercise routine through middle age can delay biological aging by up to 12 years, according to a review reported in the British Journal of Sports Medicine.

A biopharmaceutical company developing new therapies that prevent, ameliorate, or reverse both type 1 and 2 diabetes, announces its achievement of a major drug development milestone for Human proIslet Peptide(HIP).

Many African Americans getting tight blood pressure control had worsening chronic kidney disease nonetheless, a large multicenter trial found.